清瘟解热方对湿热证型病毒性肺炎大鼠肺损伤及CCL3/CCR5信号通路的作用

二维码(扫一下试试看!) 参考文献(共23条):[1] BRENNER N R, SHORR A F. The evolving burden of viruses in pneumonia[J]. Current Opinion in Infectious Diseases, 2019, 32(2): 158-162.[2] HENRY C, ZAIZAFOUN M, STOCK E, et al. Impact of angiotensin-converting enzyme inhibitors and statins on viral pneumonia[J]. Proceedings (Baylor University Medical Center), 2018, 31(4): 419-423.[3] 朱波宇, 杨璐, 王洪武, 等. 基于网络药理学探讨清瘟解热合剂治疗新型冠状病毒肺炎的作用机制[J]. 云南中医学院学报, 2020, 43(4): 71-78.[4] XIE P F, FANG Y, SHEN Z L, et al. Broad antiviral and anti-inflammatory activity of Qingwenjiere mixture against SARS-CoV-2 and other human coronavirus infections[J]. Phytomedicine, 2021, 93: 153808.[5] ZHANG S J, CHEN Z, LI G W, et al. Effect of the Haoqinqingdan Decoction on damp-heat syndrome in rats with influenza viral pneumonia[J]. Asian Pacific Journal of Tropical Medicine, 2013, 6(8): 653-657.[6] 毕倩宇, 张桂菊, 崔有利, 等. 甘露消毒丹对湿热证型病毒性肺炎小鼠模型的多靶点干预作用[J]. 时珍国医国药, 2019, 30(8): 1840-1844.[7] BAO M, HOFSINK N, PLÖSCH T. LPS versus Poly I: C model: Comparison of long-term effects of bacterial and viral maternal immune activation on the offspring[J]. American Journal of Physiology Regulatory, Integrative and Comparative Physiology, 2022, 322(2): R99-R111.[8] CHEN F, QU F, JIA Y H, et al. Xiao-Chai-hu decoction ameliorates poly (I:C)-induced viral pneumonia through inhibiting inflammatory response and modulating serum metabolism[J]. Evidence-Based Complementary and Alternative Medicine, 2022, 2022: 1240242.[9] XIONG B, HE L M, QIN Y Y, et al. Effectiveness of adjunctive corticosteroid therapy in patients with severe COVID-19: A retrospective cohort study[J]. World Journal of Clinical Cases, 2021, 9(15): 3546-3558.[10] HU Y, WANG T P, HU Z M, et al. Clinical efficacy of glucocorticoid on the treatment of patients with COVID-19 pneumonia: A single-center experience[J]. Biomedecine & Pharmacotherapie, 2020, 130: 110529.[11] 张大方. 药理与中药药理实验[M]. 上海: 上海科学技术出版社, 2002: 10.[12] 陈弋, 王琛, 徐秋英, 等. 两种岭南湿热证小鼠模型肠道菌群动态变化的研究[J]. 世界科学技术-中医药现代化, 2020, 22(7): 2186-2197.[13] 周燕萍, 高清华, 李华锋, 等. 3种温病治法对温病湿热证模型血脂影响的对比研究[J]. 中医药学刊, 2006, 24(2): 368-369.[14] 吕文亮. 湿邪与血脂代谢异常关系的探讨[J]. 河南中医学院学报, 2004, 19(3): 5-6.[15] PATEL VK, SHIRBHATE E, PATEL P, et al. Corticosteroids for treatment of COVID-19: effect, evidence, expectation and extent[J]. Beni-suef University Journal of Basic And Applied Sciences, 2021, 10(1):78.[16] INDU M S, NARAYANANKUTTY A, RAMAVARMA S K, et al. Desmodium gyrans dc modulates lipid trafficking in cultured macrophages and improves functional high-density lipoprotein in male wistar rats[J]. Indian Journal of Pharmacology, 2021, 53(4): 286-293.[17] KHANORIA R, CHAUHAN R, SARNA R, et al. Re-expansion pulmonary edema-a rare entity: A thin line between pulmonary and cardiac decompensation[J]. Indian Journal of Critical Care Medicine, 2021, 25(3): 343-345.[18] YUE L D, GAO C, LI J Y, et al. Chemotaxis-guided self-propelled macrophage motor for targeted treatment of acute pneumonia[J]. Advanced Materials, 2023, 35(20): e2211626.[19] ZHU L Q, LY H, LIANG Y Y. PLC-γ1 signaling plays a subtype-specific role in postbinding cell entry of influenza A virus[J]. Journal of Virology, 2014, 88(1): 417-424.[20] FAN K W, JIA Y P, WANG S, et al. Role of Itk signalling in the interaction between influenza A virus and T-cells[J]. The Journal of General Virology, 2012, 93(Pt 5): 987-997.[21] DEMPSEY E C, NEWTON A C, MOCHLY-ROSEN D, et al. Protein kinase C isozymes and the regulation of diverse cell responses[J]. American Journal of Physiology Lung Cellular and Molecular Physiology, 2000, 279(3): L429-L438.[22] HAMMERSCHMIDT S, VOGEL T, JOCKEL S, et al. Protein kinase C inhibition attenuates hypochlorite-induced acute lung injury[J]. Respiratory Medicine, 2007, 101(6): 1205-1211.[23] CHICHGER H, GRINNELL K L, CASSERLY B, et al. Genetic disruption of protein kinase Cδ reduces endotoxin-induced lung injury[J]. American Journal of Physiology Lung Cellular and Molecular Physiology, 2012, 303(10): L880-L888. 相似文献(共20条):[1] 刘温娟,黄爱霞,鲁立文.miR-326在LPS诱导的急性肺损伤大鼠模型中的作用 及对NF-κB信号通路的影响[J].河北医学,2019,25(3).[2] 周璇,程方平.清热化湿方对温病湿热证模型大鼠血清TNF-α IL-1βSIgA的影响[J].辽宁中医药大学学报,2007,9(2):142-143.[3] 沈钦华,李素娟,董苏一.黄芪多糖对流感病毒性肺炎大鼠肺组织NLRP3信号通路的影响[J].山西医科大学学报,2021(9):1154-1159.[4] 高展翔,王晓萍,林培政,吴智兵.蒿芩清胆汤及其化裁方对病毒性肺炎湿热证小鼠炎性细胞因子的影响[J].广州中医药大学学报,2011,28(2):171-175.[5] 周璇 程方平(指导).清热化湿方对温病湿热证模型大鼠血清TNF-α IL-1β SIgA的影响[J].辽宁中医药大学学报,2007,9(2):142-143.[6] 万强,田静,韩晓红,黄晓佩.大黄素对重症急性胰腺炎大鼠肺损伤的保护作用及对MAPK通路的影响[J].浙江中医药大学学报,2021,45(4):331-338.[7] 韩欣,丁晓玲,余涛,包蕊,王馨.益肺散结方对肺纤维化大鼠模型自噬及PI3K-AKT-mTOR通路的影响[J].西部医学,2021,33(1):38-43.[8] 庄凌云,张桂菊,崔有利,毕倩宇,季旭明.三仁汤对湿热证型病毒性肺炎模型小鼠免疫功能的干预作用[J].山东中医药大学学报,2019(5):508-512.[9] 刘家生,王亿平,茅燕萍,刘玲,方琦.清肾颗粒对慢性肾衰竭湿热证患者血清超敏C反应蛋白及同型半胱氨酸的干预作用[J].成都中医药大学学报,2011,34(2):30-34.[10] 李红艳,李华.运脾化湿方对湿热证小儿急性非感染性腹泻病症状缓解及肠道微生态的影响[J].世界中西医结合杂志,2022,17(1):179-183.[11] 薛晓倩,黄学宽,高宁,刘鄂湖.自制方化湿液对湿阻证大鼠胃黏膜的保护作用及对表皮生长因子受体表达的影响[J].第三军医大学学报,2011(18):1928-1931.[12] 王玉芝.预防性应用玉屏银屑方对湿热证型银屑病动物模型细胞免疫功能影响[J].辽宁中医药大学学报,2013(10):22-24.[13] 张伟 林树青.刺五加对大鼠油酸型肺损伤的防治作用及机理研究[J].长春中医药大学学报,2000,16(4):50-51.[14] 徐邦杰,符德玉,周训杰,李建华,姚磊,桂明泰,谭圆圆,戴建,金露,卫洪昌.活血潜阳方对血瘀阳亢痰浊型SHR大鼠胰岛素抵抗及胰岛素信号通路的影响[J].上海中医药大学学报,2014(3):57-62.[15] 清瘟败毒饮对脓毒症急性肺损伤大鼠p38MAPK和JAK2/STAT3信号通路的干预作用[J].中医学报[16] 刘金莲,吕美豫,南海鹏,邸松蕊,梁唯灿,王林元,张建军,王淳.对清利湿热方降低高尿酸血症湿热内蕴证大鼠血尿酸的作用及机制研究[J].北京中医药大学学报,2022(12):1257-1265.[17] 陈宁,黄燕.艾氯胺酮对抑郁大鼠的作用效果及对cAMP-PKA-CREB信号通路的影响[J].四川医学,2019,40(8):785-789.[18] 何晓瑾,王磊,王瑞瑞,邱亦江.骨痹方对大鼠膝骨关节炎PI3K/AKt信号通路及组织形态学的影响[J].南京中医药大学学报,2018,34(2):157-161.[19] 王宝君,谢培凤,郭翔宇,周晖,胡浩,王颖,乔羽,王晓磊,王春红,胡燕.清热泄浊方联合苯溴马隆治疗无症状高尿酸血症湿热证疗效及对血清炎性因子的影响[J].世界中西医结合杂志,2022(9):1788-1791+1796.[20] 阙铁生,李曙光,吕军影,常丽萍,何雪萍.温病湿热证大鼠IL-17的变化及加味藿朴夏苓汤干预对其的影响[J].广西医科大学学报,2014,31(6):912-916.
相关知识
连花清瘟治疗病毒类呼吸系统传染病 多项药效研究公布
多项药效研究证实:连花清瘟可有效治疗病毒类呼吸系统传染病
从药效研究分析连花清瘟防治呼吸系统传染病关键点
连花清瘟胶囊药理的作用
连花清瘟治疗病毒性呼吸系统疾病有效性述评
抗新冠肺炎中药连花清瘟胶囊化学成分与临床功效研究进展
连花清瘟胶囊(颗粒)抗病毒药理作用及临床应用研究进展
连花清瘟的抗疫分子机理研究揭晓
中医药分期论治小儿病毒性肺炎的研究进展
连花清瘟对新冠病毒的作用
原文链接: 清瘟解热方对湿热证型病毒性肺炎大鼠肺损伤及CCL3/CCR5信号通路的作用 https://m.huajiangbk.com/newsview772849.html
| 上一篇: 浙江省2002 | 下一篇: 病毒性带状疱疹可以喝茶吗 |


